Comparison of IV Lignocain and IV Dexmedetomidine for Attenuation of Laryngoscopic Stress Response to Direct Laryngoscopy

NCT07385040 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

62

Enrollment

OTHER

Sponsor class

Conditions

Tachycardia
Hypertension
Mean Arterial Pressure

Interventions

DRUG: Intravenous Dexmedetomidine infusion
DRUG: Intravenous Lignocain

Sponsor

Shaheed Mohtarma Benazir Bhutto Institue of Trauma